|
Real-time Estimate
Cboe BZX
10:48:53 2026-05-21 am EDT
|
5-day change
|
1st Jan Change
|
|
546.36 USD
|
-1.30%
|
 |
+2.66%
|
-19.14%
|
|
Mar. 26 |
IDEXX Laboratories, Inc. Announces Departure of Nimrata Hunt as Executive Vice President, Global Strategy and Commercial, Effective April 13, 2026
|
CI
| |
Feb. 13 |
IDEXX Laboratories, Inc. Announces Retirement of M. Anne Szostak as Director
|
CI
| |
Jan. 13 |
IDEXX Laboratories, Inc. Announces Chief Executive Officer Changes, Effective May 12, 2026
|
CI
| |
Jan. 13 |
IDEXX Laboratories, Inc. Announces Management Changes, Effective May 12, 2026
|
CI
| |
Jan. 13 |
IDEXX appoints insider Michael Erickson as new CEO
|
RE
| |
Jan. 13 |
IDEXX Laboratories Names Michael Erickson as CEO, President
|
MT
| |
Jan. 13 |
IDEXX appoints insider Michael Erickson as new CEO
|
RE
| |
Jan. 13 |
Idexx announces CEO succession
|
RE
| |
Nov. 10 |
Idexx Laboratories Insider Sold Shares Worth $6,629,014, According to a Recent SEC Filing
|
MT
| |
25-10-07 |
IDEXX Laboratories Elects Karen Peacock as Director, Effective October 6, 2025
|
CI
| |
25-08-15 |
Idexx Laboratories Inc Insider Sold Shares Worth $263,814, According to a Recent SEC Filing
|
MT
| |
25-08-13 |
Idexx Laboratories Insider Sold Shares Worth $787,840, According to a Recent SEC Filing
|
MT
| |
25-08-11 |
Idexx Laboratories Inc Insider Sold Shares Worth $5,279,893, According to a Recent SEC Filing
|
MT
| |
25-08-11 |
Idexx Laboratories Inc Insider Sold Shares Worth $18,491,642, According to a Recent SEC Filing
|
MT
| |
25-07-10 |
IDEXX Laboratories, Inc. Elects Joseph L. Hooley as an Independent Class III Director, as A Member of Its Audit Committee and Governance and Corporate Responsibility Committee, Effective July 10, 2025
|
CI
| |
25-07-10 |
Idexx Laboratories elects Joseph L. (Jay) Hooley to board of directors
|
RE
| |
25-02-14 |
IDEXX Laboratories, Inc. Announces Resignation of Dr. Asha Collins from the Board of Directors
|
CI
| |
25-02-10 |
Idexx Laboratories Insider Sold Shares Worth $1,397,835, According to a Recent SEC Filing
|
MT
| |
24-11-21 |
IDEXX Laboratories CFO Brian McKeon to Retire; Andrew Emerson Named Successor
|
MT
| |
24-11-21 |
IDEXX Laboratories, Inc. Announces Executive Changes
|
CI
| |
24-11-12 |
IDEXX Laboratories, Inc. Announces Resignation of Jonathan W. Ayers from the Board and Finance Committee
|
CI
| |
24-03-07 |
Idexx Laboratories Insider Sold Shares Worth $790,427, According to a Recent SEC Filing
|
MT
| |
24-03-07 |
Idexx Laboratories Insider Sold Shares Worth $4,525,596, According to a Recent SEC Filing
|
MT
| |
24-02-09 |
Idexx Laboratories Insider Sold Shares Worth $6,871,319, According to a Recent SEC Filing
|
MT
| |
24-02-09 |
Idexx Laboratories Insider Sold Shares Worth $13,295,975, According to a Recent SEC Filing
|
MT
|
No results for this search Select your edition All financial news and data tailored to specific country editions | 
